Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03869060 · ClinicalTrials.gov registry record · Phase 1
Expansion of a Dengue-1 Live Virus Human Challenge
A Phase 1 study, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT03869060 is a Phase 1 study that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 9 participants.
The verdict
NCT03869060, a Phase 1 study, has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
To evaluate the effectiveness of candidate dengue vaccine formulations, it is prudent to develop an appropriate challenge model. This study supports the expansion of the data set of the current Dengue 1 Live Virus Human Challenge (DENV-1-LVHC) model to produce uncomplicated dengue-like illness.
Interventions
- BIOLOGICAL Dengue-1 Virus-Live Virus Human Challenge (DENV-1-LVHC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-03-11 |
| Est. Completion | 2019-09-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03869060
The ClinicalTrials.gov registry entry for NCT03869060 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dengue-1 Virus-Live Virus Human Challenge (DENV-1-LVHC) is the first listed.
NCT03869060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03869060 about?
NCT03869060 is a clinical study titled "Expansion of a Dengue-1 Live Virus Human Challenge". To evaluate the effectiveness of candidate dengue vaccine formulations, it is prudent to develop an appropriate challenge model. This study supports the expansion of the data set of the current Dengue 1 Live Virus Human Challenge (DENV-1-LVHC) model to produce uncomplicated dengue-like illness.
What is the current status of trial NCT03869060?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2019-03-11. Estimated completion is 2019-09-20.
What interventions are being tested in trial NCT03869060?
The interventions under investigation include: Dengue-1 Virus-Live Virus Human Challenge (DENV-1-LVHC) (BIOLOGICAL).
Who is sponsoring clinical trial NCT03869060?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.